Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.37
-0.06 (-1.35%)
At close: Aug 15, 2025, 3:59 PM
4.33
-0.92%
After-hours: Aug 15, 2025, 04:23 PM EDT

Vanda Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-27.21M -29.49M -4.91M -5.32M -4.52M -4.15M -2.4M 137K 1.52M 3.25M 6.86M 3.27M 2.57M -6.43M 7.08M 7.77M 9.65M 8.65M
Depreciation & Amortization
-2.79M 1.98M 1.97M 1.97M 1.97M 2.22M 1.16M 580K 602K 670K 663K 678K 690K 702K 706K 708K 712K 715K
Stock-Based Compensation
2.11M 2.97M 2.86M 3M 2.99M 3.58M 3.27M 3.17M 3.25M 4.35M 3.78M 3.89M 3.83M 4.78M 3.77M 3.95M 3.74M 3.91M
Other Working Capital
n/a -8.23M 7.38M -8.6M 288K 8.37M 4.75M -10.27M -6.62M 23.86M 7.13M 8.38M -1.41M -14.25M 1.91M -1.31M 3.1M 699K
Other Non-Cash Items
18.69M 1.1M -545K -1.49M -1.52M -825K -1.1M -1.88M -1.22M -524K -959K -521K 344K 629K 704K 991K 897K 773K
Deferred Income Tax
-7.97M -7.8M -1.91M -3.09M -1.23M -246K -7.48M 2.73M 1.46M 2.01M 417K -1.84M -1.87M 4.42M 1.31M 2.53M 1.75M 1.16M
Change in Working Capital
1.91M -1.91M 718K -9.64M -4.61M 6.98M 2.82M -6.78M -18.83M 22.04M -1.35M 7.36M 114K -50K 13.03M -6.55M 2.27M -6.01M
Operating Cash Flow
-15.25M -33.15M -1.82M -14.58M -6.93M 7.57M -3.73M -2.05M -13.22M 31.8M 9.42M 12.84M 5.68M 4.05M 26.61M 9.4M 19.02M 9.19M
Capital Expenditures
-299K -436K -214K -161K -108K -7K -253K -24K -55K -51K -263K -148K -193K -75K -134K 10K -298K -130K
Cash Acquisitions
n/a n/a n/a n/a n/a -2.71M -100.67M -35.35M 190.84M 655K -75.69M 21.63M 14.4M n/a -12K n/a n/a -12K
Purchase of Investments
-52.97M -43.33M -92.4M -83.73M -112.63M -76.01M -54.98M -46.65M -247.93M -163.04M -4.31M -168.96M -96.85M -79.13M -105.27M -117.83M -104.29M -93.06M
Sales Maturities Of Investments
38M 87.67M 96.61M 95.95M 99M 60.5M 112.11M 82M 57.09M 350.39M 80M 147.34M 82.45M 90.08M 79.41M 101.24M 70.41M 93.26M
Other Investing Acitivies
n/a n/a n/a n/a -1.52M -2.71M 57.13M 35.35M -190.84M -655K 75.69M -21.63M -14.4M 10.94M 12K -16.6M -33.88M 12K
Investing Cash Flow
-15.27M 43.9M 3.99M 12.06M -15.26M -18.22M -43.78M 35.33M -190.89M 187.29M 75.43M -21.78M -14.59M 10.87M -26M -16.59M -34.18M 71K
Debt Repayment
n/a -409K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -915K n/a n/a n/a n/a n/a n/a n/a n/a 605K 4K 125K n/a 1.04M 371K 289K 1.85M
Financial Cash Flow
-425K -1.32M n/a n/a n/a n/a n/a n/a n/a n/a 605K 4K 125K n/a 1.04M 371K 289K 1.85M
Net Cash Flow
n/a 9.48M 1.82M -2.46M -22.2M -10.66M -47.37M 33.16M -204.14M 219.14M 85.63M -8.88M -8.7M 14.86M 1.55M -6.78M -14.89M 11.1M
Free Cash Flow
-15.55M -33.58M -2.03M -14.74M -7.04M 7.56M -3.98M -2.07M -13.28M 31.75M 9.15M 12.69M 5.49M 3.97M 26.47M 9.41M 18.72M 9.06M